Henning Lauterbach

Immunology and Microbiology · Life Sciences

17h-index1.9kcitations58works2.82yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(30), Virus-based gene therapy research(24), Viral Infections and Outbreaks Research(19), Immune Cell Function and Interaction(8), vaccines and immunoinformatics approaches(8)

Publications58 total

848 The long-lasting expression of recombinant artLCMV following intraperitoneal administration exerts potent antitumor effects on tumor models of peritoneal carcinomatosis
Regular and Young Investigator Award Abstracts·2025Open Access
The long-lasting expression of recombinant artLCMV following intraperitoneal administration exerts potent antitumor effects on tumor models of peritoneal carcinomatosis
OncoImmunology·2025Open Access
Combining local cytokine delivery and systemic immunization with recombinant artLCMV boosts antitumor efficacy in several preclinical tumor models
OncoImmunology·2025· 1 citedOpen Access
1480 Eseba-vec (HB-200) plus pembrolizumab as first-line treatment of recurrent/metastatic HPV16-positive head and neck cancer: updated results in PD-L1 CPS ≥20 patients
2024· 1 citedOpen Access
1033 An Arenavirus-based immunotherapy designed to target a wide range of tumors expressing cancer testis antigens PRAME and MAGE-As
Regular and Young Investigator Award Abstracts·2024Open Access
Arenavirus-Based Vectors Generate Robust SIV Immunity in Non-Human Primates
Vaccines·2024· 4 citedOpen Access
Flt3 agonist enhances immunogenicity of arenavirus vector-based simian immunodeficiency virus vaccine in macaques
Journal of Virology·2024· 4 citedOpen Access
Development of an arenavirus-based immunotherapy for treatment of KRAS mutant cancer.
Journal of Clinical Oncology·2024
HB-200 arenavirus-based immunotherapy plus pembrolizumab as first-line treatment of patients with recurrent/metastatic HPV16-positive head and neck cancer: Updated results.
Journal of Clinical Oncology·2024· 11 cited
Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C
Journal for ImmunoTherapy of Cancer·2024· 5 citedOpen Access
Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatment
Journal for ImmunoTherapy of Cancer·2024· 5 citedOpen Access
A replicating LCMV-based vaccine for the treatment of solid tumors
Molecular Therapy·2023· 5 citedOpen Access
Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys
npj Vaccines·2023· 6 citedOpen Access
Alternating Arenavirus Vector Immunization Generates Robust Polyfunctional Genotype Cross-Reactive Hepatitis B Virus–Specific CD8 T-Cell Responses and High Anti–Hepatitis B Surface Antigen Titers
The Journal of Infectious Diseases·2023· 6 citedOpen Access
HB-300, a novel arenavirus-based cancer immunotherapy in patients with metastatic castration-resistant prostate cancer.
Journal of Clinical Oncology·2023
Abstract 5747: A novel combination therapy of arenavirus vectors and PD1-IL2v strongly potentiates tumor specific T cell responses resulting in synergistic anti-tumor efficacy
Cancer Research·2023
Preclinical development of a first-in-class vaccine encoding HER2, Brachyury and CD40L for antibody enhanced tumor eradication
Scientific Reports·2023· 5 citedOpen Access
Abstract 2048: <i>In vitro</i> and <i>in vivo</i> characterization of non-oncolytic engineered arenavirus vectors for cancer immunotherapy
Cancer Research·2022
Abstract 4198: Evaluation of a cancer immunotherapy with engineered arenavirus vectors and 4-1BB agonists in a preclinical tumor model
Cancer Research·2022
Abstract 3284: HB-201 and HB-202, an arenavirus-based immunotherapy, induces tumor T cell infiltration in patients with HNSCC and other HPV16+ tumors
Cancer Research·2022· 6 cited
page 1 of 3Next →

Frequent Co-authors

Hubertus Hochrein(22), Paul Chaplin(19), Klaus K. Orlinger(17), Barbara Bathke(14), Mark Suter(14), Maria Hinterberger(9), Ronny Kassub(9), Raphael Giessel(8), Sarah Ahmadi-Erber(8), Josipa Raguz(7), Igor Matushansky(7), Sarah Schmidt(6), Christian A. Luber(5), Meredith O’Keeffe(5), Jürgen Hausmann(5), José Medina‐Echeverz(5), Marco Testori(5), Marlene Geiger(5), Giovanna Fiore(5), Pedro Berraondo(5)